United Kingdom · Investor

Wellcome Trust

Last cheque observed Aug 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGovernment

SeedSeries ASeries BHealth-techPharmaceuticalsTranscriptomics

Cheques on record
0%of best year0cheques in 12 months, 64 on record
Since the last cheque2638days00hrs00min00sec
Median round$30MRounds led0 of 64Sole investor13 roundsExits9 from the portfolioMostly inUnited States, 67%
Pitch Wellcome Trust

Wellcome Trust highlights

  1. 01

    64 rounds on record

  2. 02

    Mostly Series B and Series C: 55% of its rounds

  3. 03

    Sole investor in 13 rounds, median $6.9M

  4. 04

    9 exits from the portfolio

What they do

Type
Government (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowthPre-IPO
Sectors
Health-techPharmaceuticalsTranscriptomics
Based in
London, United Kingdom
Cold pitches
Not stated

The record

Every round we can evidence, newest first64 appearances

  1. 2019

    2 rounds

  2. Aug
    KinetaUS · FinSMEs$1.8MSole investor
  3. Mar
    Karuna TherapeuticsSeries B · US · FinSMEs$68MWith 8 others
  4. 2018

    4 rounds

  5. Nov
    OMassSeries A · GB · Innovation$18MSole investor
  6. Aug
    Karuna PharmaSeries A · US · FinSMEs$42MWith 3 others
  7. Jun
    KarunaUS · FinSMEs$8.0MSole investor
  8. Mar
    DoorDashSeries D · US · FinSMEs$535MWith 2 others
  9. 2015

    1 round

  10. Jan
    Verne GlobalSeries D$98MWith 3 others
  11. 2014

    5 rounds

  12. Oct
    OmnioxGrant · US$5.8MSole investor
  13. Aug
    Airstrip TechnologiesVenture · US$25MWith 2 others
  14. May
    KymabSeries B · GB$40MWith 1 other
  15. Apr
    Integrated DiagnosticsSeries B · US$30MWith 2 others
  16. Apr
    Phononic DevicesSeries D · US$45MWith 1 other
  17. 2013

    3 rounds

  18. Nov
    BiocartisSeries E · CH · finsmes.com$39MWith 5 others
  19. Sept
    TreventisSeed · US · finsmes.com$4.4MSole investor
  20. May
    Trino TherapeuticsSeries A · IE · pevc.dowjones.com$12MWith 1 other
  21. 2012

    6 rounds

  22. Oct
    Airstrip TechnologiesVenture · US · pevc.dowjones.com$10MSole investor
  23. Jul
    Siluria TechnologiesSeries C · US · marketwire.com$30MWith 8 others
  24. Jul
    Cell MedicaGB · finsmes.com$26MWith 2 others
  25. May
    Castlight HealthSeries D · US · techcrunch.com$100MWith 7 others
  26. Feb
    Integrated DiagnosticsSeries A · US · integrated-diagnostics.com$10MWith 1 other
  27. Feb
    Radius HealthSeries C · US · onbiovc.com$21MWith 6 others
  28. 2011

    8 rounds

  29. Dec
    PTC TherapeuticsGrowth · US · finsmes.com$5.0MSole investor
  30. Dec
    Radius HealthGrowth · US$21MWith 6 others
  31. Nov
    SapiensSeries B · DE · finsmes.com$13MSole investor
  32. Nov
    BiocartisSeries C · CH · finsmes.com$96MWith 2 others
  33. Sept
    Siluria TechnologiesSeries B · US · finsmes.com$20MWith 6 others
  34. Jul
    Radius HealthSeries C · US · onbiovc.com$66MWith 6 others
  35. Mar
    Beyond OblivionGrowth · US · paidcontent.org$77MWith 1 other
  36. Feb
    WongaSeries C · GB · eu.techcrunch.com$117MWith 2 others
  37. 2010

    6 rounds

  38. Oct
    CellBiosciencesSeries F · US · xconomy.com$20MWith 7 others
  39. Jul
    KymabSeries A · GB · kymab.com$30MSole investor
  40. Jun
    Castlight HealthSeries C · US · freshnews.com$60MWith 6 others
  41. Apr
    Biota HoldingsVenture · AU$423KSole investor
  42. Apr
    AchaogenSeries C · US · pr-inside.com$56MWith 6 others
  43. Jan
    Nabriva TherapeuticsSeries B · AT · onbiovc.com$22MWith 7 others
  44. 2009

    7 rounds

  45. Nov
    OxagenSeries C · GB · fiercebiotech.com$27MWith 8 others
  46. Oct
    Integrated DiagnosticsSeries A · US · onbiovc.com$30MWith 1 other
  47. Oct
    Pacific BiosciencesSeries E · US · onbiovc.com$68MWith 13 others
  48. Jun
    Chroma TherapeuticsVenture · GB$25MWith 5 others
  49. Jun
    VaxInnateSeries D · US · onbiovc.com$30MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Funds they back

1 fund commitment on record

Managers
1

Every fund on record that it has committed money to, and the managers who invest it.Source: fund news.

Managers it backs most

Exits from the portfolio

Companies it backed that were later bought or listed9 in all

SapiensBought by Medtronic$200MAug 2014
CellBiosciencesBought by Bio-TechneUndisclosedJun 2014
AmplimmuneBought by AstraZeneca$500MAug 2013
Five Prime TherapeuticsListedUndisclosedJul 2013
PTC TherapeuticsListed$125MJun 2013
Aton PharmaBought by Valeant Pharmaceuticals International$318MMay 2010
Fovea PharmaceuticalsBought by Sanofi AventisUndisclosedOct 2009
Sirtris PharmaceuticalsBought by GlaxoSmithKline$720MApr 2008
Ionix PharmaceuticalsBought by VernalisUndisclosedJul 2005

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Wellcome Trust. A count of rooms they were both in, not a relationship either has claimed.

HealthCare VenturesGrowth equity8rounds togetherAbingworthVC firm7rounds togetherMPM CapitalPrivate equity7rounds togetherARCH Venture PartnersVC firm5rounds togetherBB Biotech VenturesGrowth equity5rounds togetherDomain AssociatesVC firm5rounds togetherFLAG Capital Management, LLCGrowth equity5rounds togetherInterWest PartnersVC firm4rounds togetherKleiner Perkins Caufield & ByersVC firm4rounds togetherVenrockVC firm4rounds togetherAlloy VenturesVC firm3rounds togetherBrookside CapitalHedge fund3rounds together

Recently backed

The latest companies Wellcome Trust put money into.

DoorDash$535M · Mar 2018

On podcasts

1 episode naming Wellcome Trust in the title, and 3 more that mention it.

Mentioned in

Quick answers about Wellcome Trust

What does Wellcome Trust invest in?

Wellcome Trust invests most often at Series B and Series C (55% of the rounds on record), in sectors such as Health-tech, Pharmaceuticals and Transcriptomics.

How active is Wellcome Trust?

64 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2019.

What has Wellcome Trust invested in recently?

Its most recent investments on record: Kineta (Undisclosed round, Aug 2019), Karuna Therapeutics (Series B, Mar 2019) and OMass (Series A, Nov 2018).

How big are Wellcome Trust's cheques?

The median round it joins is $30M.

Does Wellcome Trust lead rounds?

Rarely, if at all: none of its 64 investments on record names it as the lead.

Where does Wellcome Trust invest?

Most of the companies it backs are in the United States (67%), the United Kingdom (18%) and Switzerland (5%).

Is Wellcome Trust investing now?

No investments in the last 12 months; the latest was in Aug 2019.

Who does Wellcome Trust invest alongside?

Most often HealthCare Ventures (8 rounds together), Abingworth (7 rounds together) and MPM Capital (7 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it